Search research articles
Contact Us
Filters
Showing results (91-100 of 185) with videos related to
Page
of 19
Sort By:
Biomedical Chromatography : BMC
|
August 28, 2025
Validation of a Dried Blood Spot Method for the Determination of a Third-Generation Bcr-Abl 1 Inhibitor, Vodobatinib, in Small Volumes of Rat Blood: Application to a Pharmacokinetic Study
Ashok Zakkula, Keerthana Madipelli, Niranjan Veerla, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 6, 2017
LC-MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice
Neeraj Kumar Saini, P S Suresh, Mahalakhsmi Lella, et al.
Biomedical Chromatography : BMC
|
November 5, 2011
Development and validation of an LC-MS/MS-ESI method for the determination of lorglumide, a CCK-1 antagonist in mouse plasma: application to a pharmacokinetic study
Kuldeep Sharma, Anitha Police, Avinash Kumar, et al.
Bioanalysis
|
January 22, 2011
LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies
Kuldeep Sharma, Radhe Raman Singh, Murugesh Kandaswamy, et al.
Biopharmaceutics & Drug Disposition
|
September 24, 2004
Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats
Kota Jagannath, Madhusudana Rao Chaluvadi, Ramesh Mullangi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 24, 2017
Highly sensitive UHPLC-MS/MS method for the simultaneous estimation of propafenone and its metabolites 5-hydroxypropafenone and N-depropylpropafenone on human dried blood spots technique and application to a pharmacokinetic study
Adinarayana Andy, Raja Reddy Kallem, Ramesh Mullangi, et al.
Drug Research
|
June 19, 2026
Preclinical Assessment and Tissue Distribution of Vodobatinib, a Third Generation BCr-Abl 1 Inhibitor
Sandeep Kaddare, Rama Murthi Bestha, Niranjan Veerla, et al.
Biomedical Chromatography : BMC
|
December 28, 2024
Highly Sensitive LC-MS/MS Method for Determination of Dexamethasone in Rat Plasma and Brain Tissue: An Application to Pharmacokinetic Study in Rats
Rama Murthi Bestha, Ashok Zakkula, Madipelli Keerthana, et al.
Biomedical Chromatography : BMC
|
April 28, 2015
Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study
Anitha Police, Sandip Gurav, Vinay Dhiman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 30, 2004
Development and validation of a chiral liquid chromatographic method, based on Chiralpak to quantify enantiomers of (+/-)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(-)-DRF 2725) to its antipode in plasma
S Syed Mustafa, Ravikumar Trivedi, N V S R Mamidi, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 185) with videos related to
Sort By:
Page
of 19
Biomedical Chromatography : BMC
|
August 28, 2025
Validation of a Dried Blood Spot Method for the Determination of a Third-Generation Bcr-Abl 1 Inhibitor, Vodobatinib, in Small Volumes of Rat Blood: Application to a Pharmacokinetic Study
Ashok Zakkula, Keerthana Madipelli, Niranjan Veerla, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 6, 2017
LC-MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice
Neeraj Kumar Saini, P S Suresh, Mahalakhsmi Lella, et al.
Biomedical Chromatography : BMC
|
November 5, 2011
Development and validation of an LC-MS/MS-ESI method for the determination of lorglumide, a CCK-1 antagonist in mouse plasma: application to a pharmacokinetic study
Kuldeep Sharma, Anitha Police, Avinash Kumar, et al.
Bioanalysis
|
January 22, 2011
LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies
Kuldeep Sharma, Radhe Raman Singh, Murugesh Kandaswamy, et al.
Biopharmaceutics & Drug Disposition
|
September 24, 2004
Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats
Kota Jagannath, Madhusudana Rao Chaluvadi, Ramesh Mullangi, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 24, 2017
Highly sensitive UHPLC-MS/MS method for the simultaneous estimation of propafenone and its metabolites 5-hydroxypropafenone and N-depropylpropafenone on human dried blood spots technique and application to a pharmacokinetic study
Adinarayana Andy, Raja Reddy Kallem, Ramesh Mullangi, et al.
Drug Research
|
June 19, 2026
Preclinical Assessment and Tissue Distribution of Vodobatinib, a Third Generation BCr-Abl 1 Inhibitor
Sandeep Kaddare, Rama Murthi Bestha, Niranjan Veerla, et al.
Biomedical Chromatography : BMC
|
December 28, 2024
Highly Sensitive LC-MS/MS Method for Determination of Dexamethasone in Rat Plasma and Brain Tissue: An Application to Pharmacokinetic Study in Rats
Rama Murthi Bestha, Ashok Zakkula, Madipelli Keerthana, et al.
Biomedical Chromatography : BMC
|
April 28, 2015
Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study
Anitha Police, Sandip Gurav, Vinay Dhiman, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
July 30, 2004
Development and validation of a chiral liquid chromatographic method, based on Chiralpak to quantify enantiomers of (+/-)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(-)-DRF 2725) to its antipode in plasma
S Syed Mustafa, Ravikumar Trivedi, N V S R Mamidi, et al.
Page
of 19